Clinical Trial

A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Healthy Adults

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate whether blood levels of sonrotoclax after administration of a tablet for oral suspension are similar to those observed with the current sonrotoclax tablet. In addition, this study evaluates the effect of food on the absorption of sonrotoclax after administration of the tablet for oral suspension and the resulting blood levels of sonrotoclax.
Trial Details
NCT Number NCT07628881
Lead Sponsor BeOne Medicines
Conditions Healthy Volunteers
Enrollment 12 participants
Start Date 2026-06-18
Primary Completion 2026-09-27 (estimated)
Study Completion 2026-09-27 (estimated)
Updated on ClinicalTrials.gov 2026-06-05